Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A clinical update on the significance of the gut microbiota in systemic autoimmunity.
Response to 'Re. Doppler Ultrasound Examination of Multiple Sclerosis Patients and Control Participants: Inter-observer Agreement and Association with Disease'
N'-(arylsulfonyl)pyrazoline-1-carboxamidines as novel, neutral 5-hydroxytryptamine 6 receptor (5-HT₆R) antagonists with unique structural features.
Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis.
Diffusion abnormality in Balo's concentric sclerosis: clues for the pathogenesis.
Cytosolic phospholipase A2 plays a crucial role in ROS/NO signaling during microglial activation through the lipoxygenase pathway.
Effect of Multiple Sclerosis Disease-Modifying Therapies on B Cells and Humoral Immunity.
Tracking successive Wallerian degenerations in a relapsing-remitting multiple sclerosis patient.
Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease.
Phenotyping primary human microglia: tight regulation of LPS responsiveness.
Gilenya® data confirm reducing brain shrinkage matters for people with MS due to its association with long-term disability progression
Inflammation-independent defective early B cell tolerance checkpoints in rheumatoid arthritis.
[A young woman with central facial nerve palsy].
Celastrol and Its Role in Controlling Chronic Diseases.
Corpus callosum thickness in children: an MR pattern-recognition approach on the midsagittal image.
Cutaneous Adverse Events in the Randomized, Double-Blind, Active-Comparator DECIDE Study of Daclizumab High-Yield Process Versus Intramuscular Interferon Beta-1a in Relapsing-Remitting Multiple Sclerosis.
Genetics of rat neuroinflammation.
Health Care Resource Utilization Associated with Pediatric Patients Diagnosed with Relapsing Remitting Multiple Sclerosis.
Electrical and Network Neuronal Properties Are Preferentially Disrupted in Dorsal, But Not Ventral, Medial Entorhinal Cortex in a Mouse Model of Tauopathy.
Pramipexole, a Dopamine D2/D3 Receptor-Preferring Agonist, Prevents Experimental Autoimmune Encephalomyelitis Development in Mice.
[Acute kidney injury (AKI) requireing renal replacement therapy in a patient treated with intravenous immunoglobulin].
Clinical Overlap of Multiple Sclerosis and Autoimmune Hepatitis: Three Cases.
Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Aβ accumulation and memory deficits.
Catalpol induces oligodendrocyte precursor cell-mediated remyelination in vitro.
Reduced Sterol Regulatory Element-Binding Protein (SREBP) Processing Through Site-1 Protease (S1P) inhibition Alters Oligodendrocyte Differentiation in vitro.
Pages
« first
‹ previous
…
727
728
729
730
731
732
733
734
735
…
next ›
last »